Pakistan decides to temporarily suspend the clinical trial of hydroxychloroquine on corona patients
ISLAMABAD: Special Health Assistant Dr. Zafar Mirza has said that Pakistan has decided to temporarily suspend the clinical trial of hydroxychloroquine on Corona patients.
According to details, Special Health Assistant Dr. Zafar Mirza said in his message on the social networking website that a meeting was held with the executive group on corone tracheal trial and the group decided to temporarily suspend the clinical trial of hydroxychloroquine.
Earlier this month, the Corona Expert Advisory Group had decided to immediately stop using the anti-malarial drug Coroquine on Corona patients. Doing so endangers lives.
Professor Saqib had said that chloroquine, hydroxychloroquine is causing irregular heartbeat. In the first study, the use of chloroquine had beneficial effects.
The World Health Organization (WHO) has suspended experiments with hydroxychloroquine for the treatment of corona due to safety concerns, with Tedros saying the ban is temporary.
The Executive Group of the Solidarity Trial, representing 10 countries, met on Saturday and has agreed to review by temporarily suspending clinical trial of hydroxychloroquine in COVID-19 patients. High mortality has been reported! <310> https://t.co/a5vtSHolRI
— Zafar Mirza (@zfrmrza) May 26, 2020